Human Oncology & Pathogenesis Program
The Charles Sawyers Lab
Research

Dr. Sawyers is investigating the signaling pathways that drive the growth of cancer cells, with an eye toward designing new treatment options for patients with chronic myeloid leukemia, prostate cancer, and glioblastoma.

Featured News
Publications
People

Charles L. Sawyers, MD
Investigator, Howard Hughes Medical Institute; Marie-Josée and Henry R. Kravis Chair in Human Oncology and Pathogenesis; Chair, Human Oncology and Pathogenesis Program
- Human Oncology and Pathogenesis Program Chair Charles Sawyers develops molecularly targeted cancer therapy.
- MD, Johns Hopkins University School of Medicine
- sawyersc@mskcc.org
- Email Address
- 646-888-2138
- Office Phone
- View physician profile
- Physician profile
Members

- 646-888-2163
- Lab Phone
- 646-888-2595
- Lab Fax


- Massachusetts Institute of Technology

- University of Wisconsin, Madison

- BS, Zhongshan University





- Rijksuniversiteit Groningen, Groningen, The Netherlands














- Cornell University

Assistant Attending, Laboratory Member

Associate Attending

Senior Research Scientist

Assistant Lab Member

Postdoctoral Researcher at Memorial Sloan Kettering Cancer Center, New York, NY

Research Fellow

Research Technician

NE WGS Graduate Student

Assistant to Chairman

Research Fellow

Senior Research Technician

Research Assistant

Research Technician

Senior Research Technician


Research Technician

Research Technician

Senior Research Assistant


Research Fellow

Research Fellow

Assistant Attending

Research Technician

Senior Research Scientist

Fellow

Fellow

Research Scholar

- University of California, Los Angeles


- Peking Union Medical College

- Carol Davila University of Medicine, Bucharest, Romania
- Harvard University

- Weill Medical College of Cornell University, New York, PhD
- Peking University, Beijing, BS

- UCLA



- University of Michigan




- New York University



- Cornell University

- University of Pennsylvania School of Medicine

- Vanderbilt University

- Rutgers University, University of Medicine and Dentistry New Jersey
- 646-888-2594
- Office Fax
- 646-888-2163
- Lab Phone

- MD, Weill Cornell Medical College
- PhD, The Rockefeller University
- Cornell University
- Viterbo University, LaCrosse, WI
- 646-888-2163
- Lab Phone
- 646-888-2595
- Lab Fax
Lab Alumni

Clinical Scientist, Nektar Therapeutics, San Francisco, CA

Research Fellow

Graduate Student

Medical Oncology Fellow

Senior Research Scientist

Research Fellow
Senior Research Scientist
Research Technician

GSK Graduate Student
Research Technician

MD/PhD Student

Research Lab Manager

Research Fellow

Assistant to the Chairman

Research Fellow

Senior Animal Husbandry Technician
Fellow

Fellow

Research Technician
Research Technician

Research Fellow

Research Technician

Senior Research Technician
NE WGS Graduate Student
Research Associate

Research Technician

Research Fellow
Graduate Research Assistant


Research Fellow

Research Technician


Lab Head

Research Fellow
Research Technician


Lab Affilations
- Human Oncology & Pathogenesis Program
- Memorial Hospital Research Laboratories
- Department of Medicine
- Center for Experimental Therapeutics
- Geoffrey Beene Cancer Research Center
- The Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center
- Brain Tumor Center
- Center for Molecular Imaging & Nanotechnology
- Gerstner Sloan Kettering Graduate School of Biomedical Sciences
Achievements
- AACR Princess Takamatsu Memorial Lectureship and Award (2019)
- The Scheele Award, Swedish Academy of Pharmaceutical Sciences (2017)
- American Cancer Society Medal of Honor (2017)
- BBVA Foundation Frontiers of Knowledge Award (2015)
- Breakthrough Prize in Life Sciences (2013)
Read more
- Lasker-DeBakey Clinical Medical Research Award (2009)
- Breakthrough Prize in Life Sciences (2013)
- Science of Oncology Award, American Society of Clinical Oncology (2013)
- Stanley J. Korsmeyer Award, American Society of Clinical Investigation (2011)
- Member, National Academy of Sciences (2010)
- Lasker~DeBakey Clinical Medical Research Award, Lasker Foundation (2009)
- Dorothy Landon-AACR Prize for Translational Cancer Research, American Association for Cancer Research (2009)
- Member, Institute of Medicine of the National Academies (2008)
- David A. Karnofsky Memorial Award, American Society of Clinical Oncology (2005)
Get in Touch
-
Lab Head Email
-
Office Phone
-
Office Fax
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Charles L. Sawyers discloses the following relationships and financial interests:
-
Agios Pharmaceuticals
Ownership / Equity Interests; Provision of Services -
Annual Review of Cancer Biology
Provision of Services -
Arsenal IO Canada Parent, Inc.
Ownership / Equity Interests; Provision of Services -
BeiGene, Ltd.
Ownership / Equity Interests; Provision of Services -
Blueprint Medicines
Ownership / Equity Interests; Provision of Services -
Column Group
Ownership / Equity Interests; Provision of Services -
Diaprost AB
Intellectual Property Rights -
Flagship Investments, Ltd.
Ownership / Equity Interests -
Foghorn Therapeutics
Ownership / Equity Interests; Provision of Services
-
Harrington Discovery Institute
Provision of Services -
Housey Pharmaceutical
Ownership / Equity Interests; Provision of Services -
KSQ Therapeutics
Ownership / Equity Interests; Provision of Services -
Nextech Venture, LTD
Ownership / Equity Interests; Provision of Services -
Novartis
Fiduciary Role/Position; Ownership / Equity Interests -
Oric Pharmaceuticals
Intellectual Property Rights; Ownership / Equity Interests; Provision of Services -
PMV Pharma
Ownership / Equity Interests; Provision of Services -
Petra Pharma Corporation
Ownership / Equity Interests; Provision of Services
The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2019 through disclosure submission in spring 2020). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at ecoi@mskcc.org.